4.49 (-%)
As of Nov 01, 2024
Source:
Tenax Therapeutics is clinical-stage therapies with the potential to substantially improve the treatment of patients with serious cardiovascular and pulmonary vascular diseases. Our extensive experience in these fields allows us to distinguish promising treatments with sound scientific rationales that can meaningfully address unmet medical needs. We consider both new chemical entities and strategies to repurpose existing products.
Country | United States |
Headquarters | chapel hill, north carolina |
Phone Number | 919-855-2100 |
Industry | services |
CEO | Christopher T. Giordano |
Website | www.tenaxthera.com |